ERBB2 and breast neoplasm: Martyna Michalska et al. (Michalska et al., 2016) designed peptide LTVSPWY functionalized alloyed CuInZnxS2+x quantum dots as a fluorescent nanoprobe of HER2-positive breast tumors, and peptide LTVSPWY worked for targeted binding to HER2.